Airway Medix Spółka Akcyjna financials
Airway Medix Spółka Akcyjna
259400MDMODKWHZ2EU17 | Line item | 2021 | 2020 |
|---|---|---|
| Income statement | ||
| Revenue | PLN 6.0K | PLN 257.0K |
| Other income | PLN 20.1M | PLN 92.0K |
| Raw materials & consumables used | PLN 0 | PLN 0 |
| Depreciation & amortisation | PLN 0 | PLN 0 |
| Finance costs | PLN 1.5M | PLN 767.0K |
| Profit before tax | -PLN 9.4M | -PLN 2.0M |
| Income tax expense | -PLN 2.3M | PLN 388.0K |
| Profit for the year | -PLN 7.0M | -PLN 2.4M |
| — attributable to owners | -PLN 7.0M | -PLN 2.4M |
| — attributable to NCI | PLN 0 | PLN 0 |
| Total comprehensive income | -PLN 6.7M | -PLN 2.2M |
| Per share | ||
| Basic EPS | PLN -0.12 | PLN -0.04 |
| Diluted EPS | PLN -0.12 | PLN -0.04 |
| Free cash flow / share | PLN -0.10 | PLN -0.04 |
| Cash flow statement | ||
| Net cash from operating activities | -PLN 5.9M | -PLN 2.2M |
| Net cash from investing activities | PLN 0 | -PLN 5.0M |
| Purchase of PP&E (capex) | PLN 0 | PLN 7.0K |
| Net cash from financing activities | PLN 3.7M | PLN 8.7M |
| Proceeds from borrowings | PLN 3.7M | PLN 9.9M |
| Repayments of borrowings | PLN 0 | PLN 917.0K |
| Lease liability payments | PLN 0 | PLN 215.0K |
| Net change in cash | -PLN 2.1M | PLN 1.5M |
| Balance sheet | ||
| Total assets | PLN 44.5M | PLN 51.5M |
| Non-current assets | PLN 38.6M | PLN 29.0M |
| Property, plant & equipment | PLN 89.0K | PLN 2.4M |
| Current assets | PLN 5.9M | PLN 22.4M |
| Inventories | PLN 332.0K | PLN 220.0K |
| Trade & other receivables | PLN 510.0K | PLN 780.0K |
| Cash & equivalents | PLN 29.0K | PLN 2.2M |
| Total equity | PLN 23.9M | PLN 30.7M |
| — attributable to owners | PLN 23.9M | PLN 30.7M |
| Non-controlling interests | PLN 0 | PLN 0 |
| Non-current liabilities | PLN 2.3M | PLN 7.9M |
| Long-term borrowings | PLN 131.0K | PLN 117.0K |
| Lease liabilities (non-current) | PLN 0 | PLN 2.6M |
| Current liabilities | PLN 18.3M | PLN 13.0M |
| Lease liabilities (current) | PLN 0 | PLN 121.0K |
| Trade & other payables | PLN 3.8M | PLN 2.1M |
| Deferred tax liabilities | PLN 357.0K | PLN 3.3M |
| Derived metrics | ||
| Free cash flow | -PLN 5.9M | -PLN 2.3M |
| Net margin | -117400.0% | -923.7% |
| Return on equity | -29.5% | -7.7% |
| Cash conversion ratio | 0.83× | 0.95× |
| Capex coverage | — | -321.14× |
| Other reported items | ||
| Adjustments For Decrease Increase In Inventories | -PLN 112.0K | -PLN 29.0K |
| Adjustments For Decrease Increase In Trade and Other Receivables | -PLN 638.0K | PLN 336.0K |
| Adjustments For Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | PLN 14.3M | PLN 19.0K |
| Adjustments For Increase Decrease In Employee Benefit Liabilities | PLN 759.0K | -PLN 194.0K |
| Adjustments For Increase Decrease In Trade and Other Payables | PLN 1.7M | -PLN 194.0K |
| Adjustments For Unrealised Foreign Exchange Losses Gains | PLN 639.0K | -PLN 332.0K |
| Basic Earnings Loss Per Share From Continuing Operations | PLN -0.12 | PLN -0.04 |
| Basic Earnings Loss Per Share From Discontinued Operations | PLN 0.00 | PLN 0.00 |
| Capital Reserve | PLN 2.0M | PLN 2.0M |
| Changes In Equity | -PLN 6.8M | -PLN 2.2M |
| Comprehensive Income Attributable To Noncontrolling Interests | PLN 0 | PLN 0 |
| Comprehensive Income Attributable To Owners of Parent | -PLN 6.7M | -PLN 2.2M |
| Current Assets Other Than Assets Or Disposal Groups Classified As Held For Sale Or As Held For Distribution To Owners | PLN 5.9M | PLN 22.4M |
| Current Borrowings and Current Portion of Noncurrent Borrowings | PLN 13.2M | PLN 10.3M |
| Current Contract Assets | PLN 0 | PLN 14.5M |
| Current Liabilities Other Than Liabilities Included In Disposal Groups Classified As Held For Sale | PLN 18.3M | PLN 13.0M |
| Current Provisions For Employee Benefits | PLN 1.2M | PLN 367.0K |
| Current Tax Assets Current | PLN 0 | PLN 0 |
| Current Tax Liabilities Current | PLN 87.0K | PLN 30.0K |
| Deferred Tax Assets | PLN 787.0K | PLN 1.4M |
| Diluted Earnings Loss Per Share From Continuing Operations | PLN -0.12 | PLN -0.04 |
| Diluted Earnings Loss Per Share From Discontinued Operations | PLN 0.00 | PLN 0.00 |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | -PLN 46.0K | PLN 46.0K |
| Equity and Liabilities | PLN 44.5M | PLN 51.5M |
| Expense By Nature | PLN 1.8M | PLN 2.2M |
| Finance Income | PLN 406.0K | PLN 995.0K |
| Impairment Loss On Receivables Or Contract Assets Arising From Contracts With Customers | PLN 14.3M | PLN 312.0K |
| Income Taxes Paid Refund Classified As Operating Activities | -PLN 45.0K | PLN 65.0K |
| Increase Decrease In Cash and Cash Equivalents | -PLN 2.2M | PLN 1.5M |
| Increase Decrease Through Transfers and Other Changes Equity | -PLN 85.0K | PLN 14.0K |
| Intangible Assets Other Than Goodwill | PLN 37.7M | PLN 25.3M |
| Issued Capital | PLN 19.9M | PLN 19.9M |
| Liabilities | PLN 20.6M | PLN 20.8M |
| Liabilities Included In Disposal Groups Classified As Held For Sale | PLN 0 | PLN 0 |
| Miscellaneous Other Operating Expense | PLN 12.3M | PLN 45.0K |
| Noncurrent Assets Or Disposal Groups Classified As Held For Sale Or As Held For Distribution To Owners | PLN 0 | PLN 0 |
| Noncurrent Government Grants | PLN 1.5M | PLN 1.5M |
| Noncurrent Provisions For Employee Benefits | PLN 321.0K | PLN 349.0K |
| Other Adjustments For Noncash Items | -PLN 431.0K | PLN 230.0K |
| Other Adjustments For Which Cash Effects Are Investing Or Financing Cash Flow | -PLN 27.3M | PLN 0 |
| Other Adjustments To Reconcile Profit Loss | PLN 110.0K | -PLN 33.0K |
| Other Comprehensive Income | PLN 377.0K | PLN 183.0K |
| Other Comprehensive Income Net of Tax Exchange Differences On Translation | PLN 377.0K | PLN 183.0K |
| Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net of Tax | PLN 377.0K | PLN 183.0K |
| Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss Net of Tax | PLN 0 | PLN 0 |
| Other Current Financial Assets | PLN 5.0M | PLN 4.7M |
| Other Expense By Nature | PLN 0 | PLN 0 |
| Other Shortterm Provisions | PLN 67.0K | PLN 54.0K |
| Payments For Development Project Expenditure | PLN 0 | PLN 5.0M |
| Profit Loss From Continuing Operations | -PLN 7.0M | -PLN 2.4M |
| Profit Loss From Discontinued Operations | PLN 0 | PLN 0 |
| Reserve of Exchange Differences On Translation | PLN 869.0K | PLN 492.0K |
| Reserve of Sharebased Payments | PLN 1.1M | PLN 1.1M |
| Retained Earnings | -PLN 1.1M | PLN 6.0M |
| Services Expense | PLN 1.4M | PLN 1.9M |
| Share Premium | PLN 1.2M | PLN 1.2M |
| Social Security Contributions | PLN 5.0K | PLN 4.0K |
| Tax Expense Other Than Income Tax Expense | PLN 13.0K | PLN 70.0K |
| Wages and Salaries | PLN 310.0K | PLN 225.0K |
Every line item above is a fact tagged in Airway Medix Spółka Akcyjna's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (PLN), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.